NASDAQ
Black Diamond Therapeutics, Inc. (BDTX) reported revenue of $70.00M and net income of $22.37M for FY 2025, with a net profit margin of 32.0%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.